Medical/Pharmaceuticals
Harbour BioMed Reports 2021 Interim Results
CAMBRIDGE, Mass.and SUZHOU, China and ROTTERDAM, Netherlands, Aug. 31, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, reported its interim...
2021-08-31 13:47
4337
InnoCare Announces Clearance by U.S. FDA of Clinical Trial of pan-TRK Inhibitor ICP-723
BEIJING, Aug. 30, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biopharmaceutical company, announced today the Investigational New Drug (IND) clearance of its second-generation pan-TRK inhibitor ICP-723 by the US Food and Drug Administration (FDA) for starting phase I cli...
2021-08-31 08:30
3156
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix
SEOUL, South Korea, Aug. 30, 2021 /PRNewswire/ -- CancerRop (180400), a company specializing in precision medicine and molecular diagnostics, announced a jump start in the global vaccine hub for COVID-19 mRNA (messenger ribonucleic acid) with Hanmi Science through20 billion won worth of investmen...
2021-08-30 23:00
3930
I-Mab Announces Upcoming Participation at September Conferences
SHANGHAI and GAITHERSBURG, Md., Aug. 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Septem...
2021-08-30 20:00
2238
GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science
SUZHOU, China, Aug. 29, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry leading biopharmaceutical company dedicated to next generation bioconjugate drugs through innovative intelligent ligase-dependent conjugation (iLDC) technology platform, announces the appointment of Dr.Yi Xia as Seni...
2021-08-30 10:00
2617
InnoCare Releases 2021 Half Year Results and Business Highlights
BEIJING, Aug. 29, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2021 half year results which ended onJune 30, 2021. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, "On the fo...
2021-08-29 19:49
5314
IONOVA Life Science Announces New Financing Round of USD $100 Million
SHENZHEN, China, Aug. 27, 2021 /PRNewswire/ -- On August 27, 2021, Shenzhen IONOVA Life Science Co., Ltd. ("IONOVA" or "the company"), a clinical-stage biotechnology company located in theGuangdong-Hong Kong-Macao Greater Bay Area ofChina, announced completion of a new financing round of USD $100...
2021-08-27 22:00
3483
Bunshi Lab Starts Accepting Pre-orders for "Bunshi Mask" -- Best-selling Crowdfunded Face Mask in Japan -- through "Indiegogo" Crowdfunding Website
FUKUOKA, Japan, Aug. 27, 2021 /PRNewswire/ -- Bunshi Lab ("bunshi" meaning molecule in Japanese) has raised approximately180 million yen (*1) for the "Bunshi Mask" through "Makuake," a Japanese crowdfunding website. Now, Bunshi Lab is launching a much-awaited global sales campaign for the product...
2021-08-27 16:00
1765
Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer
SHANGHAI and WAREN, New Jersey, Aug. 26, 2021 /PRNewswire/ -- Laekna Therapeutics announced today that the Center for Drug Evaluation (CDE), the National Medical Products Administration (NMPA) ofChina has approved the Investigational New Drug (IND) application of its Category 1 new drug candidate...
2021-08-27 11:20
2050
PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services
NANJING, China, Aug. 26, 2021 /PRNewswire/ -- PharmaBlock (300725.SZSE), an innovative chemistry products and services provider to support drug discovery, development, and commercialization, announces the appointment of Dr.Xudong Wei as Senior Vice President and Head of CDMO Business to enhance s...
2021-08-26 23:00
4433
3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development
HONG KONG, Aug. 26, 2021 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today unveiled its 2021 interim results. 3SBio maintained strong performance in core businesses, with core products occupying a leading market share. Meanwhile, the Company continuously increased ...
2021-08-26 22:09
6914
Aqueous Ozone by BES Group Proves Effective in Killing COVID-19
SAN ANTONIO, Aug. 25, 2021 /PRNewswire/ -- Aqueous ozone by BES Group's
Multi-Purpose Ozone Bottle and Professional Ozone Spray Bottle has proved
effective in killing SARS-CoV-2, the virus that causes COVID-19 in testing by a
third-party lab at Nara Medical University inJapan.
2021-08-25 22:00
3691
First patient treated in Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial
SYDNEY, Aug. 25, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or the "Company"), an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing need in oncology, is pleased to announce that the first US patient has ...
2021-08-25 21:18
6705
Tigermed Reports 2021 Interim Results with Strong Financial Growth
HANGZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (stock code: 300347.SZ / 3347.HK), a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, reports its interim results for the six months endedJune 30, 202...
2021-08-25 20:49
6953
ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility
* $20 million investment for a new Mfg & R&D facility * Strategic platform for partnering & CDMO business SEOUL, South Korea, Aug. 25, 2021 /PRNewswire/ -- ExoCoBio Inc., the 4th largest exosome player in the world, announced the initiation of its "Project EGMP", starting with the constructio...
2021-08-25 19:44
3739
Senhwa Biosciences Announces Dose Escalation Initiation of the Phase I Trial of Pidnarulex as a Treatment for Advanced Hematological Malignancies
TAIPEI and SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced the initiation of Dose Escalation within the Phase I Investigator Init...
2021-08-25 19:00
2216
Ocumension Acquires all the Equity Interests in Two Ophthalmic Products Mainland China, Further Enhancing its Pipeline Strength
HONG KONG, Aug. 25, 2021 /PRNewswire/ -- Beijing time, August 24, 2021, Ocumension Therapeutics announced that it has entered into a product acquisition agreement with a leading global pharmaceutical company Novartis, pursuant to which the Company will acquire all the equity interests in two oph...
2021-08-25 12:35
4506
CBC-led Consortium Acquires Significant Equity Interest in Korea's Largest Medical Aesthetics Company
SEOUL, South Korea, Aug. 24, 2021 /PRNewswire/ -- A consortium led by CBC Group ("CBC") announced today the signing of definitive agreements to acquire a 46.9% equity interest (the "Transaction") in Hugel, Inc. ("Hugel", 145020.KQ) from Bain Capital. The market capitalization of Hugel is appro...
2021-08-25 07:50
3203
Solbasium Unveils the World's First Red Light Therapy Roller
SYDNEY, Aug. 24, 2021 /PRNewswire/ -- Global leader in red light therapy, Solbasium, has today unveiled a world-first muscle roller using this innovative technology. The Quantum Roller features 256 powerful LEDs across the body, alongside a three-speed vibration intensity, and has been specifical...
2021-08-24 23:07
2873
Ping An Good Doctor posts 39% revenue growth in the first half of 2021; Revenue from medical services grows 50.6%; Total number of registered users reaches 400 million
HONG KONG and SHANGHAI, Aug. 24, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 01833.HK), a leading online medical and healthcare service platform in China, has announced its 2021 interim results. During the reporting period, the Compan...
2021-08-24 23:03
6755
Week's Top Stories
Most Reposted
Agoda and Singapore Tourism Board Expand Partnership to Boost Demand and Tech Transformation in Tourism
[Picked up by 314 media titles]
2026-08-14 10:00
Agoda Launches AI-Powered Room Grid Bot to Help Travelers Decide Which Room to Book
[Picked up by 313 media titles]
2026-08-13 12:00
PARKROYAL COLLECTION Marina Bay, Singapore Named Among Singapore's Top 10 Hotels by Travel + Leisure and Featured on 50 Best Discovery
[Picked up by 313 media titles]
2026-08-14 12:27
GCash Parent Mynt Cited as Sole Philippine Firm in World's Top Fintech Companies List
[Picked up by 296 media titles]
2026-08-12 16:02
Appier Delivers Record-High Revenue, Profitability and Core Free Cash Flow
[Picked up by 295 media titles]
2026-08-13 23:42Most Read
AMTD IDEA's Receipt of NYSE Letter Regarding ADS Trading Price's Below Compliance Standards
2026-08-08 04:01
17738
Two CityUHK scholars elected to the European Academy of Engineering in recognition of their internationally acclaimed research achievements
2026-08-10 19:12
14926
GCash Parent Mynt Cited as Sole Philippine Firm in World's Top Fintech Companies List
2026-08-12 16:02
8888